Project Grant R01DK137913

Award Date 9/10/24
Completion Date 5/31/29
Dollars Obligated $1.6M
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15222, USA
Similar Awards
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research to determine the developmental origins and regulation of dermal adipose tissue. The $121,875 award, granted on April 5, 2025, will be performed by the University of Pennsylvania and aims to: (1) elucidate the mechanisms by which the transcription factor BCL11B...
This $391,250 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support research on extracellular vesicle-dependent RNA signaling in metabolism. The project aims to identify key proteins involved in the delivery of adipose microRNAs into liver cells via extracellular vesicles, and to determine if this RNA delivery mechanism is necessary for...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $893,250 to the Pennington Biomedical Research Center in Baton Rouge, Louisiana. The funding supports research to elucidate the roles of the protein KAT8 in adipocyte (fat cell) function and its impact on systemic metabolic health, including lipoatrophy and insulin resistance. The project aims to provide...
This $409,375 federal Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports research at The Johns Hopkins University to understand the contribution of hepatic fatty acid oxidation to hepatic and systemic metabolic homeostasis. The research aims to describe novel requirements and signaling roles of hepatic fatty acid oxidation that...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $840,198 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Dana-Farber Cancer Institute, Inc. (Dfci) in Boston, MA. The goal of this 4-year project is to better understand the mechanisms of energy expenditure and adipose thermogenesis in mammalian systems, with a focus on the futile creatine cycle pathway. Key objectives include determining how...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $659,199 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Pittsburgh. The grant, awarded on February 25, 2025, supports research to investigate a novel pathway by which hepatocyte-derived growth differentiation factor 15 (GDF15) can improve obesity-associated insulin resistance independent of changes in body weight and the GDF15...
This federal Project Grant award of $152,454 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research on the mechanistic role of the protein irisin in modulating immune response and adipose tissue dynamics. The primary awardee, Dana-Farber Cancer Institute, Inc., will conduct a multi-year study to: (1) elucidate the molecular pathways through which irisin...
This federal Project Grant award, titled "Defining the Role of IGF2 in Regulating Adipocyte Progenitor Proliferation and Adipogenesis", is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $358,524 award will support research conducted by the University of Pittsburgh to investigate the role of insulin-like growth factor 2 (IGF2) in regulating...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $793,500 to the University of Pittsburgh to conduct a mechanistic study of PEG-asparaginase-induced liver injury. The primary goals are to: 1) demonstrate that inhibiting adipose triglyceride lipase (ATGL)-mediated white adipose tissue lipolysis can attenuate PEG-asparaginase-induced...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $243,590 to the University of Chicago to study the role of the mitophagy receptor BNIP3 in regulating lipid homeostasis in the liver. The goal is to define the mechanisms by which BNIP3 decreases lipid droplet content through promoting mitophagy and lipophagy, particularly in the...

This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $1,618,520.00 to the University of Pittsburgh to conduct research on a novel lysosomal mechanism of adipocyte lipolysis. The project aims to define the molecular and cell biological mechanisms governing mobilization of fatty acids from adipocytes during fasting, as well as the role of the lysosomal lipolysis pathway in systemic lipid homeostasis and energy balance. The project will leverage innovative methods including inducible adipocyte targeted loss of function studies, multi-omics analysis of transcription factor regulatory circuitry, and high-resolution imaging mass spectrometry. A sub-award of an unspecified amount was made to Brigham & Women's Hospital Inc. to contribute specialized research expertise to the project.

Generated 8/5/25, 2:53 AM